With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
TORONTO, March 3, 2017 – Canada’s largest meeting devoted to the rapidly evolving field of heart failure is coming to the Metro Toronto Convention Centre this spring.
The Ted Rogers Centre for Heart Research has united with the Canadian Heart Failure Society to create Heart Failure Update 2017 – a unique bench-to-bedside event offering the latest information for the practicing clinician and nurse, and a simultaneous stream focused on investigative research.
Sessions will feature an interactive roster of expert plenaries, case-based panel discussions, workshops and debates targeted at health-care professionals and investigators whose focus is improved heart failure treatment and prevention.
Over 50 presenters are on tap to explore pressing issues and topics including advanced heart failure, right heart failure, genetic research, regenerative medicine, fibrosis, mechanical circulatory support, and novel therapies.
For all the details and to register, please visit HFUpdate.ca.
